Skip to main content
Caplight Logo









DropGenie

DropGenie

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://dropgenie.com/

Last Round

Seed

Jun 22, 2026

Total Funding Raised

$110,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

DropGenie is a biotechnology company that provides a microfluidics-based platform to miniaturize and automate gene editing workflows, enabling high-throughput cell engineering in precious patient samples for applications in personalized medicine and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

microfluidics platformgene editinglab automationCRISPR screeninglab-on-a-chipcell engineeringhigh-throughput screeningdrug discovery platformdigital microfluidicsHTSassay miniaturizationnon-viral transfectioncell and gene therapyfunctional genomicsAI-driven drug discoveryprimary patient cellsrazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DropGenie Comparables

Compare DropGenie with similar companies based on industry and business-model similarity.

DropGenie comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellFE
80%
Indee Labs
79%
Portal Biotechnologies
79%

DropGenie Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 22, 2026
AcceleratorMar 13, 2026
AcceleratorJul 6, 2022
AcceleratorAug 23, 2018

Key People

Founding team and executive leadership

Hugo Sinha

COO

Executive Team

Yen-Hsiang Wang

Chief Business Officer

Executive Team

DropGenie Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 2, 4x the trailing average.

  • Jun 22, 2026

    Led by Skeleton Key with participation from Merck Capital Ventures.

DropGenie Filings

Explore SEC and related filing metadata, where available.

DropGenie filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DropGenie's valuation, stock price, and market status.

Is DropGenie a public or private company?

DropGenie is a private company.

What is the current stock price of DropGenie?

DropGenie is a private company with no public stock price. No recent secondary market data is available.

How much is DropGenie worth (valuation)?

Valuation information for DropGenie is not publicly available.

Can I buy DropGenie stock?

DropGenie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DropGenie's last funding round?

DropGenie's most recent funding round was Seed on June 22, 2026.

Who are the main investors in DropGenie?

Key investors in DropGenie include Skeleton Key.

Will DropGenie IPO soon?

No public IPO plans have been announced for DropGenie.

How can I track DropGenie secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DropGenie's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range7
Year Founded2018
Last FundingJun 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?